[
    [
        {
            "time": "2023-03-15",
            "original_text": "FDA Approves AbbVie's JAK Inhibitor Application For Active Psoriatic Arthritis",
            "features": {
                "keywords": [
                    "FDA",
                    "Approves",
                    "AbbVie",
                    "JAK",
                    "Inhibitor",
                    "Psoriatic",
                    "Arthritis"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "FDA Approves AbbVie's JAK Inhibitor Application For Active Psoriatic Arthritis",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "AbbVie (ABBV) Rinvoq Gets FDA Nod for Active Psoriatic Arthritis",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Rinvoq",
                    "FDA",
                    "Psoriatic",
                    "Arthritis"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "AbbVie (ABBV) Rinvoq Gets FDA Nod for Active Psoriatic Arthritis",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "Lilly (LLY) Phase III Study in Ulcerative Colitis Meets Goal",
            "features": {
                "keywords": [
                    "Lilly",
                    "Phase",
                    "III",
                    "Study",
                    "Ulcerative",
                    "Colitis"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Lilly (LLY) Phase III Study in Ulcerative Colitis Meets Goal",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "Pfizer (PFE) COVID Pill Maintains Strong Efficacy, Stock Up",
            "features": {
                "keywords": [
                    "Pfizer",
                    "COVID",
                    "Pill",
                    "Efficacy",
                    "Stock"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pfizer (PFE) COVID Pill Maintains Strong Efficacy, Stock Up",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "Idera Shares Fall After Early Tilsotolimod Data, Seeks Collaborating Partners For TLR9 Agonist",
            "features": {
                "keywords": [
                    "Idera",
                    "Shares",
                    "Fall",
                    "Tilsotolimod",
                    "Data",
                    "TLR9",
                    "Agonist"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Idera Shares Fall After Early Tilsotolimod Data, Seeks Collaborating Partners For TLR9 Agonist",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "5 Top Stock Gainers for Wednesday Before Fed's Key Policy Update",
            "features": {
                "keywords": [
                    "Top",
                    "Stock",
                    "Gainers",
                    "Fed",
                    "Policy",
                    "Update"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "general"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "5 Top Stock Gainers for Wednesday Before Fed's Key Policy Update",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "VIP Growth Opportunities Portfolio Buys Uber Technologies Inc, Lightspeed Commerce Inc, Chewy ...",
            "features": {
                "keywords": [
                    "VIP",
                    "Growth",
                    "Opportunities",
                    "Portfolio",
                    "Buys",
                    "Uber",
                    "Lightspeed",
                    "Commerce",
                    "Chewy"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "retail",
                    "consumer goods"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "VIP Growth Opportunities Portfolio Buys Uber Technologies Inc, Lightspeed Commerce Inc, Chewy ...",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "VIP Growth and Income Portfolio Buys Universal Music Group NV, Vertiv Holdings Co, Tourmaline ...",
            "features": {
                "keywords": [
                    "VIP",
                    "Growth",
                    "Income",
                    "Portfolio",
                    "Buys",
                    "Universal",
                    "Music",
                    "Group",
                    "Vertiv",
                    "Holdings",
                    "Tourmaline"
                ],
                "sentiment_score": 0.55,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "entertainment",
                    "industrial",
                    "energy"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "VIP Growth and Income Portfolio Buys Universal Music Group NV, Vertiv Holdings Co, Tourmaline ...",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "VanEck Pharmaceutical ETF Buys Sanofi SA, AstraZeneca PLC, AbbVie Inc",
            "features": {
                "keywords": [
                    "VanEck",
                    "Pharmaceutical",
                    "ETF",
                    "Buys",
                    "Sanofi",
                    "AstraZeneca",
                    "AbbVie"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "VanEck Pharmaceutical ETF Buys Sanofi SA, AstraZeneca PLC, AbbVie Inc",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]